表紙
市場調査レポート

前立腺癌治療 - パイプライン製品の分析

Prostate Cancer - Pipeline Review, 2015

発行 GlobalData 商品コード 344267
出版日 ページ情報 英文 353 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
前立腺癌治療 - パイプライン製品の分析 Prostate Cancer - Pipeline Review, 2015
出版日: 2015年10月01日 ページ情報: 英文 353 Pages
概要

当レポートでは、立腺癌治療のパイプライン製品について調査分析し、主要なパイプライン製品、主要企業、開発段階別のパイプライン製品、主な臨床試験データ、最近の動向について、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 立腺癌治療の概要

第3章 開発中の製品

  • 立腺癌治療 - パイプライン製品:開発段階別
  • 立腺癌治療 - パイプライン製品:地域別
  • 立腺癌治療 - パイプライン製品:規制経路別
  • 立腺癌治療 - パイプライン製品:承認時期別 (予定)
  • 立腺癌治療 - 進行中の臨床試験

第4章 立腺癌治療:開発中のパイプライン製品 (企業別)

  • 立腺癌治療企業 - パイプライン製品:開発段階別
  • 立腺癌治療 - パイプライン製品:開発段階別

第5章 企業と製品の概要

  • 3D Biomatrix, LLC
  • A&G Pharmaceutical, Inc.
  • Abbott Diagnostics
  • Abnova Corporation
  • AccuTech, LLC
  • Advanced Marker Discovery, S.L.
  • Affinimark Technologies, Inc.
  • Almac Diagnostics Limited
  • AltheaDx, Inc.
  • Ambrilia Biopharma Inc.
  • Andro Diagnostics
  • Arno Therapeutics, Inc.
  • AroCell AB
  • Arrayit Diagnostics, Inc.
  • Aurelium BioPharma Inc. (休止中)
  • Bayer HealthCare AG
  • Baylor College of Medicine
  • Beckman Coulter, Inc.
  • Biocare Medical LLC
  • Biocept, Inc.
  • Biocrates Life Sciences AG
  • BioMark Diagnostics Inc.
  • BioMark Technologies Inc.
  • bioMerieux S.A.
  • Biomoda, Inc. (休止中)
  • BioRap Technologies Ltd.
  • Biosceptre (Aust) Pty Ltd
  • Biotron Limited
  • Blondin Bioscience, LLC
  • Caldera Health Limited など

第6章 立腺癌治療:最近の動向

第7章 付録

図表

目次
Product Code: GDME0086EPD

GlobalData's Medical Devices sector report, "Prostate Cancer - Pipeline Review, 2015" provides an overview of Prostate Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Prostate Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Prostate Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prostate Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Prostate Cancer Overview

3. Products under Development

  • 3.1. Prostate Cancer - Pipeline Products by Stage of Development
  • 3.2. Prostate Cancer - Pipeline Products by Territory
  • 3.3. Prostate Cancer - Pipeline Products by Regulatory Path
  • 3.4. Prostate Cancer - Pipeline Products by Estimated Approval Date
  • 3.5. Prostate Cancer - Ongoing Clinical Trials

4. Prostate Cancer - Pipeline Products under Development by Companies

  • 4.1. Prostate Cancer Companies - Pipeline Products by Stage of Development
  • 4.2. Prostate Cancer - Pipeline Products by Stage of Development

5. Prostate Cancer Companies and Product Overview

  • 5.1. 3D Biomatrix, LLC Company Overview
  • 5.2. A&G Pharmaceutical, Inc. Company Overview
  • 5.3. Abbott Diagnostics Company Overview
  • 5.4. Abnova Corporation Company Overview
  • 5.5. AccuTech, LLC Company Overview
  • 5.6. Advanced Marker Discovery, S.L. Company Overview
  • 5.7. Affinimark Technologies, Inc. Company Overview
  • 5.8. Almac Diagnostics Limited Company Overview
  • 5.9. AltheaDx, Inc. Company Overview
  • 5.10. Ambrilia Biopharma Inc. Company Overview
  • 5.11. Andro Diagnostics Company Overview
  • 5.12. Arno Therapeutics, Inc. Company Overview
  • 5.13. AroCell AB Company Overview
  • 5.14. Arrayit Diagnostics, Inc. Company Overview
  • 5.15. Aurelium BioPharma Inc. (Inactive) Company Overview
  • 5.16. Bayer HealthCare AG Company Overview
  • 5.17. Baylor College of Medicine Company Overview
  • 5.18. Beckman Coulter, Inc. Company Overview
  • 5.19. Biocare Medical LLC Company Overview
  • 5.20. Biocept, Inc. Company Overview
  • 5.21. Biocrates Life Sciences AG Company Overview
  • 5.22. BioMark Diagnostics Inc. Company Overview
  • 5.23. BioMark Technologies Inc. Company Overview
  • 5.24. bioMerieux S.A. Company Overview
  • 5.25. Biomoda, Inc. (Inactive) Company Overview
  • 5.26. BioRap Technologies Ltd. Company Overview
  • 5.27. Biosceptre (Aust) Pty Ltd Company Overview
  • 5.28. Biotron Limited Company Overview
  • 5.29. Blondin Bioscience, LLC Company Overview
  • 5.30. Caldera Health Limited Company Overview
  • 5.31. Cancer Genetics, Inc. Company Overview
  • 5.32. Cancer Research Technology Limited Company Overview
  • 5.33. Caprion Inc. Company Overview
  • 5.34. Caris Life Sciences, Inc. Company Overview
  • 5.35. Cellanyx Diagnostics, Inc. Company Overview
  • 5.36. CellMax Life Company Overview
  • 5.37. Cellmid Limited Company Overview
  • 5.38. Cepheid Company Overview
  • 5.39. Ceres Nanosciences, Inc. Company Overview
  • 5.40. ChemImage Corporation Company Overview
  • 5.41. China Sky One Medical, Inc. Company Overview
  • 5.42. Chronix Biomedical, Inc. Company Overview
  • 5.43. Cleveland Diagnostics Inc. Company Overview
  • 5.44. CompanDX Ltd. Company Overview
  • 5.45. Courtagen Life Sciences, Inc. Company Overview
  • 5.46. CS-Keys, Inc. Company Overview
  • 5.47. Cytosystems Ltd Company Overview
  • 5.48. Dartmouth College Company Overview
  • 5.49. Detroit R&D, Inc. Company Overview
  • 5.50. Diaxonhit S.A. Company Overview
  • 5.51. Egenix, Inc. Company Overview
  • 5.52. Epigenomics AG Company Overview
  • 5.53. Euclid Diagnostics LLC Company Overview
  • 5.54. Eventus Diagnostics, Inc. Company Overview
  • 5.55. Exiqon A/S Company Overview
  • 5.56. Exosome Diagnostics, Inc. Company Overview
  • 5.57. Exosomics Siena SpA Company Overview
  • 5.58. Fluxion Biosciences, Inc. Company Overview
  • 5.59. Gene Probe, Inc. Company Overview
  • 5.60. GeneFluidics Inc. Company Overview
  • 5.61. GeneNews Limited Company Overview
  • 5.62. Genomic Health, Inc. Company Overview
  • 5.63. Georgia Institute of Technology Company Overview
  • 5.64. GILUPI Nanomedizin Company Overview
  • 5.65. GlycoZym Company Overview
  • 5.66. Health Discovery Corporation Company Overview
  • 5.67. Hologic, Inc. Company Overview
  • 5.68. Ikonisys, Inc. Company Overview
  • 5.69. Imperial College London Company Overview
  • 5.70. Inanovate (UK) Ltd. Company Overview
  • 5.71. Institut National de la Sante et de la Recherche Medicale Company Overview
  • 5.72. InterGenetics Incorporated Company Overview
  • 5.73. IRIS International, Inc. Company Overview
  • 5.74. IV Diagnostics, Inc. Company Overview
  • 5.75. KineMed, Inc. Company Overview
  • 5.76. MabCure Inc. Company Overview
  • 5.77. MacroArray Technologies, LLC. Company Overview
  • 5.78. Matritech, Inc. (Inactive) Company Overview
  • 5.79. Mayo Clinic Company Overview
  • 5.80. MDNA Life Sciences, Inc. Company Overview
  • 5.81. MDxHealth SA Company Overview
  • 5.82. Metabolomic Technologies Inc. Company Overview
  • 5.83. Metabolon, Inc. Company Overview
  • 5.84. Metanomics Health GmbH Company Overview
  • 5.85. MetaStat, Inc. Company Overview
  • 5.86. Milagen, Inc. Company Overview
  • 5.87. Minomic International Ltd Company Overview
  • 5.88. Miraculins Inc. Company Overview
  • 5.89. Nano Discovery Inc. Company Overview
  • 5.90. Neogenix Oncology, Inc. Company Overview
  • 5.91. NeoGenomics, Inc. Company Overview
  • 5.92. NeuroBioTex Inc. Company Overview
  • 5.93. Novel Bio-spectrum Technologies, Inc. Company Overview
  • 5.94. NovioGendix Holding B.V Company Overview
  • 5.95. Nuclea Biotechnologies Inc. Company Overview
  • 5.96. Numares GmbH Company Overview
  • 5.97. NuView Life Sciences, Inc. Company Overview
  • 5.98. Onconome, Inc. Company Overview
  • 5.99. ONCOVEDA Cancer Research Center Company Overview
  • 5.100. OncoVista Innovative Therapies, Inc. Company Overview
  • 5.101. On-Q-ity, Inc. (Inactive) Company Overview
  • 5.102. OPKO Health, Inc. Company Overview
  • 5.103. Orion Genomics LLC Company Overview
  • 5.104. Ortho-Clinical Diagnostics Inc. Company Overview
  • 5.105. Oryzon Genomics S.A. Company Overview
  • 5.106. OTraces Inc. Company Overview
  • 5.107. Oxford Gene Technology Limited Company Overview
  • 5.108. Panacea Pharmaceuticals, Inc. Company Overview
  • 5.109. PharmaSeq, Inc. Company Overview
  • 5.110. Predictive Biosciences, Inc. Company Overview
  • 5.111. PrognosDx Health, Inc. Company Overview
  • 5.112. Prostate Management Diagnostics, Inc Company Overview
  • 5.113. Protagen AG Company Overview
  • 5.114. Proteocyte Diagnostics Inc Company Overview
  • 5.115. ProteoMediX AG Company Overview
  • 5.116. Proteomika Company Overview
  • 5.117. Proveri Inc. Company Overview
  • 5.118. Qiagen N.V. Company Overview
  • 5.119. Quanterix Corporation Company Overview
  • 5.120. RiboMed Biotechnologies, Inc. Company Overview
  • 5.121. Rice University Company Overview
  • 5.122. Roche Diagnostics International Ltd. Company Overview
  • 5.123. Roswell Park Cancer Institute Company Overview
  • 5.124. Siamab Therapeutics, Inc. Company Overview
  • 5.125. Siemens Healthcare Diagnostics Inc. Company Overview
  • 5.126. Sienna Cancer Diagnostics Ltd Company Overview
  • 5.127. Sividon Diagnostics GmbH Company Overview
  • 5.128. Skuldtech France Company Overview
  • 5.129. Soricimed Biopharma Inc. Company Overview
  • 5.130. Source MDx Company Overview
  • 5.131. Stage I Diagnostics, Inc. Company Overview
  • 5.132. Target Discovery, Inc. Company Overview
  • 5.133. The Johns Hopkins University Company Overview
  • 5.134. Transbiomed, SL Company Overview
  • 5.135. True Diagnostics, Inc. Company Overview
  • 5.136. Tyrian Diagnostics Limited Company Overview
  • 5.137. Universite De Lyon Company Overview
  • 5.138. University of California, Los Angeles Company Overview
  • 5.139. University of Central Florida Company Overview
  • 5.140. University of Chicago Company Overview
  • 5.141. University of Colorado Company Overview
  • 5.142. University of Gottingen Company Overview
  • 5.143. University of Oslo Company Overview
  • 5.144. University of Otago Company Overview
  • 5.145. University of Pittsburgh Company Overview
  • 5.146. University of South Australia Company Overview
  • 5.147. University of South Florida Company Overview
  • 5.148. University of Strathclyde Company Overview
  • 5.149. Uppsala County Council Company Overview
  • 5.150. UroSens Ltd Company Overview
  • 5.151. US Biomarkers, Inc. Company Overview
  • 5.152. Vermillion, Inc. Company Overview
  • 5.153. Vitatex Inc. Company Overview
  • 5.154. Vitrimark, Inc. Company Overview
  • 5.155. Vitruvian Biomedical, Inc. Company Overview
  • 5.156. VolitionRX Ltd. Company Overview
  • 5.157. ZEUS Scientific, Inc. Company Overview

6. Prostate Cancer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Prostate Cancer - Pipeline Products by Stage of Development
  • Table 2: Prostate Cancer - Pipeline Products by Territory
  • Table 3: Prostate Cancer - Pipeline Products by Regulatory Path
  • Table 4: Prostate Cancer - Pipeline Products by Estimated Approval Date
  • Table 5: Prostate Cancer - Ongoing Clinical Trials
  • Table 6: Prostate Cancer Companies - Pipeline Products by Stage of Development
  • Table 7: Prostate Cancer - Pipeline Products by Stage of Development
  • Table 8: 3D Biomatrix, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: 3D Cell Assay - Metastatic Prostate Cancer - Product Status
  • Table 10: 3D Cell Assay - Metastatic Prostate Cancer - Product Description
  • Table 11: A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Companion Diagnostic Test - Prostate Cancer - Product Status
  • Table 13: Companion Diagnostic Test - Prostate Cancer - Product Description
  • Table 14: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: ERG Companion Diagnostic Assay - Product Status
  • Table 16: ERG Companion Diagnostic Assay - Product Description
  • Table 17: Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Biomarker Test - Prostate Cancer - Product Status
  • Table 19: Biomarker Test - Prostate Cancer - Product Description
  • Table 20: AccuTech, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: PSA Test - Product Status
  • Table 22: PSA Test - Product Description
  • Table 23: Advanced Marker Discovery, S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Urine Based Diagnostic Test - Prostate Cancer - Product Status
  • Table 25: Urine Based Diagnostic Test - Prostate Cancer - Product Description
  • Table 26: Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Prostalent Diagnostic Test - Product Status
  • Table 28: Prostalent Diagnostic Test - Product Description
  • Table 29: Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Prognostic Test - Metastatic Prostate Cancer - Product Status
  • Table 31: Prognostic Test - Metastatic Prostate Cancer - Product Description
  • Table 32: AltheaDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Prognostic Assay - Prostate Cancer - Product Status
  • Table 34: Prognostic Assay - Prostate Cancer - Product Description
  • Table 35: Ambrilia Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: PSP94 Immunoassay - Product Status
  • Table 37: PSP94 Immunoassay - Product Description
  • Table 38: Andro Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Diagnostic Test - Prostate Cancer - Product Status
  • Table 40: Diagnostic Test - Prostate Cancer - Product Description
  • Table 41: Arno Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Status
  • Table 43: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Description
  • Table 44: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: TK 210 Assay - Prostate Cancer - Product Status
  • Table 46: TK 210 Assay - Prostate Cancer - Product Description
  • Table 47: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Microarray-Based Diagnostic Test - Prostate Cancer - Product Status
  • Table 49: Microarray-Based Diagnostic Test - Prostate Cancer - Product Description
  • Table 50: Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Prostate Cancer Screening Test - Product Status
  • Table 52: Prostate Cancer Screening Test - Product Description
  • Table 53: Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Status
  • Table 55: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Description
  • Table 56: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Diagnostic Assay - Prostate Cancer - Product Status
  • Table 58: Diagnostic Assay - Prostate Cancer - Product Description
  • Table 59: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Diagnostic Test - Prostate Cancer - Product Status
  • Table 61: Diagnostic Test - Prostate Cancer - Product Description
  • Table 62: UniCel DxC 600i Synchron Access BPH-A Assay - Product Status
  • Table 63: UniCel DxC 600i Synchron Access BPH-A Assay - Product Description
  • Table 64: Biocare Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Clear View - Prostate Cancer - Product Status
  • Table 66: Clear View - Prostate Cancer - Product Description
  • Table 67: Biocept, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: OncoCEE-PR - Product Status
  • Table 69: OncoCEE-PR - Product Description
  • Table 70: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Metabolomic Biomarker Assay - Prostate Cancer - Product Status
  • Table 72: Metabolomic Biomarker Assay - Prostate Cancer - Product Description
  • Table 73: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Status
  • Table 75: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Description
  • Table 76: BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Biomarker Assay - Prostate Cancer - Product Status
  • Table 78: Biomarker Assay - Prostate Cancer - Product Description
  • Table 79: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: Annexin A3 Prostate Cancer Marker - Product Status
  • Table 81: Annexin A3 Prostate Cancer Marker - Product Description
  • Table 82: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
  • Table 83: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
  • Table 84: Diagnostic Assay - Prostate Cancer - Product Status
  • Table 85: Diagnostic Assay - Prostate Cancer - Product Description
  • Table 86: Screening Biomarker Assay - Prostate Cancer - Product Status
  • Table 87: Screening Biomarker Assay - Prostate Cancer - Product Description
  • Table 88: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: CyPath Diagnostic Assay - Prostate Cancer - Product Status
  • Table 90: CyPath Diagnostic Assay - Prostate Cancer - Product Description
  • Table 91: BioRap Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Biomarker Test - Prostate Cancer - Product Status
  • Table 93: Biomarker Test - Prostate Cancer - Product Description
  • Table 94: Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Prostate Cancer IHC Diagnostic Test - Product Status
  • Table 96: Prostate Cancer IHC Diagnostic Test - Product Description
  • Table 97: Biotron Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: C-Test - Prostrate Cancer - Product Status
  • Table 99: C-Test - Prostrate Cancer - Product Description
  • Table 100: Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: FACT Assay - Product Status
  • Table 102: FACT Assay - Product Description
  • Table 103: Caldera Health Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: ProscaNZ - Product Status
  • Table 105: ProscaNZ - Product Description
  • Table 106: Cancer Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 107: Next-Gen DNA Sequencing Assay - Prostate Cancer - Product Status
  • Table 108: Next-Gen DNA Sequencing Assay - Prostate Cancer - Product Description
  • Table 109: Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: IHC Based Test - Prostate Cancer - Product Status
  • Table 111: IHC Based Test - Prostate Cancer - Product Description
  • Table 112: Caprion Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Diagnostic Assay - Prostate Cancer - Product Status
  • Table 114: Diagnostic Assay - Prostate Cancer - Product Description
  • Table 115: Caris Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 116: Diagnostic Test - PSA - Product Status
  • Table 117: Diagnostic Test - PSA - Product Description
  • Table 118: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 119: Cellanyx Test - Prostate Cancer - Product Status
  • Table 120: Cellanyx Test - Prostate Cancer - Product Description
  • Table 121: Cellanyx Diagnostics, Inc. - Ongoing Clinical Trials Overview
  • Table 122: Cellanyx Test - Prostate Cancer - A Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers with Objective Algorithmic Analysis for Prostate Cancer Risk Stratification
  • Table 123: CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
  • Table 124: Diagnostic Assay - Prostate Cancer - Product Status
  • Table 125: Diagnostic Assay - Prostate Cancer - Product Description
  • Table 126: Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: Prostate Cancer - Pipeline Products by Stage of Development
  • Figure 2: Prostate Cancer - Pipeline Products by Territory
  • Figure 3: Prostate Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Prostate Cancer - Pipeline Products by Estimated Approval Date
  • Figure 5: Prostate Cancer - Ongoing Clinical Trials
Back to Top